BrainScope

BrainScope is a medical neurotech company with well-validated technology that has the potential to revolutionize brain health management. To date the company has been focused primarily on the brain injury market, where it has successfully developed and commercialized 3 biomarkers for brain injury assessment and is continuing to grow its commercial sales in the US and internationally. BrainScope’s commercial medical device for mild traumatic brain injury helps clinicians both rule out the need for a head CT scan and objectively assess concussion at the point of care in under 15 minutes. The company has a high-quality customer base of large health systems with strong demonstrated outcomes across all customers, including a 40-60% reduction in CT use and significant reduction of patient length of stay in emergency departments. BrainScope recently expanded its focus to address multiple other markets and indications, leveraging its IP and expertise to replicate our success in brain trauma and create new brain-focused biomarkers using machine learning applied to EEG. The company has developed a deep learning platform to extend its diagnostic capabilities, which has the potential to provide continuous assessment of brain health from baseline throughout an individual's lifespan and facilitate personalized medicine.